Clinical Trial Update: A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports the Phase 1/2 study of dulanermin in combination with rituximab for follicular and other low-grade CD20+ non-Hodgkin lymphoma wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Dulanermin (dulanermin)
• Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-10-07